Summary






LECTURES & BREAKOUTS


Tuesday, June 19, 2001
Time
Title Speaker
8:00 OPENING SESSION    
  Welcome and Charge for the Meeting Scott Saxman, M.D. Welcome and Charge for the Meeting   
Introduction to Lung Cancer Screening: What is the Scope of the Problem, What Are Plans for Studies with Spiral CT Screening, and Why Are Diagnostic and Therapeutic Considerations Important John C. Ruckdeschel, M.D.
Introduction to Lung Cancer Screening: What is the Scope of the Problem, What Are Plans for Studies with Spiral CT Screening, and Why Are Diagnostic and Therapeutic Considerations Important Transcript
9:00
IMAGING SECTION    
   
Characterization of Small Pulmonary Nodules and Measurements of Growth with Computer Analysis  
  Matthew Freedman, M.D.
Characterization of Small Pulmonary Nodules and Measurements of Growth with Computer Analysis  
  Anthony P. Reeves, M.D.
DiscussionTranscript
  Discussion
Discussion  
     
Characterization of Small Pulmonary Nodules with PET and Contrasted CT Scanning
  
  PET and SPECT imaging Barry A. Siegel, M.D. PET and SPECT ImagingTranscript
  Contrasted CT imaging Eric A. Hoffman, Ph.D. PET and SPECT ImagingTranscript
    Discussion Discussion
       
  Interventional Studies of Small Pulmonary Nodules  
  Fine Needle Aspiration David Yankelevitz, M.D. Fine Needle AspirationTranscript
  Percutaneous Treatment Bradford Wood, M.D. *  
       
   11:00 PATHOLOGY/CORRELATIVE STUDIES SECTION  
Cytological Diagnosis of Peripheral Lung Lesions Ruth L. Katz, M.D.
Cytology of Lesions Detected by Spiral CT: The Cornell Experience 
Cytology of Lesions Detected by Spiral CT: The Cornell Experience Madeline F. Vazquez, M.D.
Cytology of Lesions Detected by Spiral CT: The Cornell ExperienceTranscript
Discovery of Small Lesions by Pathological Examination Douglas B. Flieder, M.D. Discovery of Small Lesions by Pathological ExaminationTranscript
Histopathology of Atypical Adenomatous Hyperplasia William H. Westra, M.D. Marker: What We Know and Don't KnowTranscript
Prognostic Markers in Small Lung Adenocarcinomas Yukio Shimosato, M.D. Marker: What We Know and Don't KnowTranscript
Markers: What We Know and
Don't Know
John D. Minna, M.D. Marker: What We Know and Don't KnowTranscript
   
  
   1:30 SURGERY SECTION    
Historical Perspective of Trials Evaluating Limited vs. Extensive Resection of NSCLC

Valerie W. Rusch, M.D.

Historical Perspective of Trials Evaluating Limited vs. Extensive Resection of NSCLCTranscript 
Alternate Techniques for Surgical Resection of Lung Cancer: Video Assisted Thorascopic Surgery Scott J. Swanson, M.D.
Alternate Techniques for Surgical Resection of Lung Cancer: Video Assisted Thorascopic SurgeryTranscript
The Japanese Experience with Limited Surgical Resection in Screening Detected Tumors Junji Yoshida, M.D., Ph.D.
The Japanese Experience with Limited Surgical Resection in Screening Detected TumorsTranscript
Anatomic Considerations of Lymphatic Pathways in the Lung and Mediastinum and Its Influence on Surgical and Other Local Therapies Hisao Asamura, M.D. Anatomic Considerations of Lymphatic Pathways in the Lung and Mediastinum and Its Influence on Surgical and Other Local TherapiesTranscript
Sub-Centimeter Lung Cancer: Prevalence of Nodal Disease and Implication for Surgical Therapy Daniel L. Miller, M.D. Sub-Centimeter Lung Cancer: Prevalence of Nodal Disease and Implication for Surgical TherapyTranscript
Sentienl Lymph Node Biopsy in Lung Cancer and its Potentiol Application to Considerations of Resection of Screened NSCLC Michael J. Liptay, M.D. Sentienl Lymph Node Biopsy in Lung Cancer and its Potentiol Application to Considerations of Resection of Screened NSCLCTranscript
Summary of the Important Surgical Issues in Lung Cancer Detected by Spiral CT Screening and Proposals for Discussion Nasser K. Altorki, M.D.
Summary of the Important Surgical Issues in Lung Cancer Detected by Spiral CT Screening and Proposals for Discussion 
   
  
   3:00 DISCUSSION OF SURGERY/PATHOLOGY ISSUES AND RECOMMENDATIONS  
 

Discussion

Discussion  
   
  
7:00 RADIOTHERAPY SECTION    
  I-125 Brachytherapy Alex S.J. Chen, M.D. I-125 BrachytherapyTranscript 
  CALGB Experience with External Beam Radiotherapy Jeffrey A. Bogart, M.D. CALGB Experience with External Beam RadiotherapyTranscript 
  Stereotaxic Radiation Therapy Robert Timmerman, M.D. Stereotaxic Radiation TherapyTranscript 
  Technical Issues with Stereotaxic Radiosurgery Randall K. Ten Haken, Ph.D. Technical Issues with Stereotaxic RadiosurgeryTranscript 
  Discussion of Radiotherapeutic Issues and Recommendations Craig W. Stevens, M.D., Ph.D. Discussion of Radiotherapeutic Issues and Recommendations  
     
Wednesday, June 20, 2001
Time
Title Speaker
8:00
CHEMOTHERAPY/ALTERNATIVE DELIVERY METHODS SECTION  
Chemotherapy in Early Lung Cancer Katherine Pisters, M.D.
Chemotherapy in Early Lung CancerTranscript
Locally Delivered Therapies Jack A. Roth, M.D.
Lung Cancer Targeted Therapies: COX-2 Inhibitors, Retinoids, and Aerosolized DeliveryTranscript
Lung Cancer Targeted Therapies: COX-2 Inhibitors, Retinoids, and Aerosolized Delivery Ethan Dmitrovsky, M.D. Lung Cancer Targeted Therapies: COX-2 Inhibitors, Retinoids, and Aerosolized DeliveryTranscript 
Growth Factors and Signal Transduction Inhibitors Paul A. Bunn, Jr., M.D. Growth Factors and Signal Transduction InhibitorsTranscript
Angiogenesis Inhibitors Fadlo R. Khuri, M.D. Angiogenesis InhibitorsTranscript
Discussion of Chemotherapy / Alternative Delivery Methods Issues and Recommendations

Paul A. Bunn, Jr., M.D.

Discussion
   
   
  
10:45 SHORT SUMMARY OF RECOMMENDATIONS FROM THE DISCUSSION SECTION OF EACH GROUP  
  Imaging Matthew Freedman, M.D. Imaging Transcript 
  Pathology/Correlative Studies Edward Gabrielson, M.D. Pathology/Correlative StudiesTranscript 
  Surgery Valerie W. Rusch, M.D. SurgeryTranscript 
  Radiotherapy Laurie E. Gaspar, M.D. RadiotherapyTranscript 
  Chemotherapy/Alternative Delivery Methods Paul A. Bunn, Jr., M.D.
Chemotherapy/Alternative Delivery MethodsTranscript

*Presentations not available online.